Stay updated on Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer now shows 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T01:36:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page revision label updated from v3.3.1 to v3.3.2, indicating a minor page update. No substantive trial content appears to have changed.
    Difference
    0.1%
    Check dated 2025-12-01T16:22:17.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are automatically filled from PubMed. Revision tags updated to v3.3.1 (additions) and v3.2.0 (deletions).
    Difference
    0.1%
    Check dated 2025-11-24T12:17:46.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The notice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:22:06.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page for NCT03695510; core sections and information remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:02.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    4%
    Check dated 2025-10-05T08:43:51.000Z thumbnail image

Stay in the know with updates to Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alpha Study: Afatinib & Pembrolizumab in HNSCC Clinical Trial page.